LLY

1,096.53

-1.32%↓

JNJ

228.19

-2.26%↓

ABBV

216.7

-2.01%↓

UNH

400.27

+0.24%↑

NVS

146.82

-2.48%↓

LLY

1,096.53

-1.32%↓

JNJ

228.19

-2.26%↓

ABBV

216.7

-2.01%↓

UNH

400.27

+0.24%↑

NVS

146.82

-2.48%↓

LLY

1,096.53

-1.32%↓

JNJ

228.19

-2.26%↓

ABBV

216.7

-2.01%↓

UNH

400.27

+0.24%↑

NVS

146.82

-2.48%↓

LLY

1,096.53

-1.32%↓

JNJ

228.19

-2.26%↓

ABBV

216.7

-2.01%↓

UNH

400.27

+0.24%↑

NVS

146.82

-2.48%↓

LLY

1,096.53

-1.32%↓

JNJ

228.19

-2.26%↓

ABBV

216.7

-2.01%↓

UNH

400.27

+0.24%↑

NVS

146.82

-2.48%↓

Search

Intuitive Surgical Inc

Open

BrancheGesundheitswesen

406.75 1.16

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

405

Max

408.98

Schlüsselkennzahlen

By Trading Economics

Einkommen

22M

822M

Verkäufe

-95M

2.8B

KGV

Branchendurchschnitt

50.491

49.712

EPS

2.5

Gewinnspanne

29.648

Angestellte

17,021

EBITDA

-145M

940M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+39.62% upside

Dividenden

By Acuity

Nächstes Ergebnis

21. Juli 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-18B

148B

Vorheriger Eröffnungskurs

405.59

Vorheriger Schlusskurs

406.75

Nachrichtenstimmung

By Acuity

67%

33%

281 / 342 Ranking in Healthcare

Intuitive Surgical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Über Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
help-icon Live chat